Adenoma formation by ingenol 3,5,20-triacetate.
Twice weekly i.p. administration of ingenol 3,5,20-triacetate in phosphate buffer saline (PBS), to a group of female NMRI mice, initiated topically with DMBA in acetone, developed no skin tumor, but produced high incidence of adenomas.